IMPACT THERAP-B Shares Added to Shanghai-Shenzhen Stock Connect Programs

Stock News
Sep 07

IMPACT THERAP-B (07630) has officially announced its inclusion in the eligible securities lists for both the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs.

According to separate announcements from the Shanghai Stock Exchange and the Shenzhen Stock Exchange, the company's H-shares have been designated as eligible for these cross-border investment channels, with the change taking effect from September 7, 2026.

Following this inclusion, qualified investors from mainland China will be able to directly purchase the company's H-shares through both the Shanghai and Shenzhen exchanges, opening up new avenues for capital flow.

The company believes that being included in the Stock Connect programs will substantially broaden its investor base and is expected to enhance the trading liquidity of its H-shares in the market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10